---
$id: https://graph.org.ai/products/commodity/51142553
$type: Product
source: UNSPSC
code: "51142553"
title: "Lazabemide monohydrochloride"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lazabemide monohydrochloride

**UNSPSC Code**: 51142553
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoamine oxidase inhibitor with the molecular formula C8H10ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PI150J9ZX1, chemically known as n-(2-aminoethyl)-5-chloro-2-pyridine-carboxamide hydrochloride, but more generally known as lazabemide monohydrochloride, which bears US NIH Compound Identifier 163727. European Medicines Agency schedules lazabemide monohydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08418MIG. Most nations, for tariff purposes, schedule lazabemide monohydrochloride under HS 29333999. SMILES: C1CC(NCC1CL)C(=O)NCCN.CL.

